EGFR and head and neck squamous cell carcinoma: Wheeler and colleagues, assessing the phosphorylation specific sites Y992 and Y1068 using reverse-phase protein array, showed that intermediate or high tumor EGFR Y1068, but not Y992, phosphorylation were associated with significantly reduced PFS in a series of frozen HNSCC samples [73].